CommercialPrior AuthMedium impact
08.00.87o, Pemetrexed (Pemfexy™)
Independence Blue Cross·Oncology·Pharmacy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated their medical necessity criteria and coding requirements for Pemetrexed (Pemfexy™), a chemotherapy medication. This affects pharmacy billing and may require updated prior authorization or documentation processes for oncology treatments.
Action Required
By November 17, 2025: Billing team must review updated medical necessity criteria for Pemetrexed (Pemfexy™) and update prior authorization processes accordingly. Oncology providers should verify documentation requirements meet new criteria before prescribing. Contact IBX for specific coding changes that may affect reimbursement.